Literature DB >> 22963868

Electroclinical, MRI and surgical outcomes in 100 epileptic patients with type II FCD.

Laura Tassi1, Rita Garbelli, Nadia Colombo, Manuela Bramerio, Giorgio Lo Russo, Roberto Mai, Francesco Deleo, Stefano Francione, Lino Nobili, Roberto Spreafico.   

Abstract

Focal cortical dysplasias (FCDs) are highly epileptogenic malformations associated with drug-resistant epilepsy, susceptible to surgical treatment. Among the different types of FCD, the type II includes two subgroups based on the absence (IIa) or presence (IIb) of balloon cells. The aim of this retrospective study was to investigate possible differences in electroclinical presentations and surgical outcomes between the two subgroups in 100 consecutive surgically treated patients with type II FCDs. All patients underwent a comprehensive presurgical assessment including stereo-EEG (SEEG) when necessary. No significant differences in gender, age at epilepsy onset, duration of epilepsy, age at surgery or seizure frequency were found between the two subgroups. Patients with type IIb FCD frequently showed sleep-related epilepsy. Their peculiar electrographic pattern was characterised by localised rhythmic or pseudo-rhythmic spikes or polyspikes ("brushes") enhanced during non-REM sleep and also associated with well-localised, brief, low-voltage fast activity. The incidence and frequency of short bursts of fast discharges, interrupted by activity suppression, increased during slow-wave sleep and often recurred pseudo-periodically. The occurrence of "brushes", present in 76% of the patients with type IIb FCD, was significantly associated (p<0.001) with the presence of balloon cells. We discuss the possible pathogenetic mechanisms underlying this activity. MRI diagnosis of type II FCD was made in 93% of the patients with balloon cells (BCs), suggesting that the presence of balloon cells might be, at least partially, responsible for the MRI features. Patients had very good postsurgical outcomes (83% in Engel class I) even after a long period of follow-up.

Entities:  

Mesh:

Year:  2012        PMID: 22963868     DOI: 10.1684/epd.2012.0525

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  29 in total

1.  Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia.

Authors:  Vinit V Patil; Miguel Guzman; Angela N Carter; Geetanjali Rathore; Daniel Yoshor; Daniel Curry; Angus Wilfong; Satish Agadi; John W Swann; Adekunle M Adesina; Meenakshi B Bhattacharjee; Anne E Anderson
Journal:  Neuropathology       Date:  2015-09-18       Impact factor: 1.906

Review 2.  Nocturnal frontal lobe epilepsy.

Authors:  Lino Nobili; Paola Proserpio; Romina Combi; Federica Provini; Giuseppe Plazzi; Francesca Bisulli; Laura Tassi; Paolo Tinuper
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

3.  Sleep Related Hypermotor Seizures with a Right Parietal Onset.

Authors:  Steve A Gibbs; Michela Figorilli; Giuseppe Casaceli; Paola Proserpio; Lino Nobili
Journal:  J Clin Sleep Med       Date:  2015-08-15       Impact factor: 4.062

Review 4.  Electro-clinical-pathological correlations in focal cortical dysplasia (FCD) at young ages.

Authors:  Hans Holthausen; Tom Pieper; Peter Winkler; Ingmar Bluemcke; Manfred Kudernatsch
Journal:  Childs Nerv Syst       Date:  2014-09-27       Impact factor: 1.475

5.  Ictal and interictal source imaging on intracranial EEG predicts epilepsy surgery outcome in children with focal cortical dysplasia.

Authors:  Michel Alhilani; Eleonora Tamilia; Lorenzo Ricci; Laura Ricci; P Ellen Grant; Joseph R Madsen; Phillip L Pearl; Christos Papadelis
Journal:  Clin Neurophysiol       Date:  2020-01-20       Impact factor: 3.708

6.  Multimodal MRI profiling of focal cortical dysplasia type II.

Authors:  Seok-Jun Hong; Boris C Bernhardt; Benoit Caldairou; Jeffery A Hall; Marie C Guiot; Dewi Schrader; Neda Bernasconi; Andrea Bernasconi
Journal:  Neurology       Date:  2017-01-27       Impact factor: 9.910

7.  Can histologically normal epileptogenic zone share common electrophysiological phenotypes with focal cortical dysplasia? SEEG-based study in MRI-negative epileptic patients.

Authors:  Stanislas Lagarde; Julia Scholly; Irina Popa; Maria Paola Valenti-Hirsch; Agnès Trebuchon; Aileen McGonigal; Mathieu Milh; Anke M Staack; Béatrice Lannes; Benoît Lhermitte; François Proust; Mustapha Benmekhbi; Didier Scavarda; Romain Carron; Dominique Figarella-Branger; Edouard Hirsch; Fabrice Bartolomei
Journal:  J Neurol       Date:  2019-05-04       Impact factor: 4.849

8.  Increased expression of TRPC5 in cortical lesions of the focal cortical dysplasia.

Authors:  Guang-Zhen Xu; Hai-feng Shu; Hai-Yun Yue; Da-Hai Zheng; Wei Guo; Hui Yang
Journal:  J Mol Neurosci       Date:  2014-08-02       Impact factor: 3.444

9.  Clinical characteristics, pathological features and surgical outcomes of focal cortical dysplasia (FCD) type II: correlation with pathological subtypes.

Authors:  Kun Yao; Xi Mei; Xingzhou Liu; Zejun Duan; Changqing Liu; Yu Bian; Zhong Ma; Xueling Qi
Journal:  Neurol Sci       Date:  2014-04-18       Impact factor: 3.307

10.  Diagnosis and surgical treatment of non-lesional temporal lobe epilepsy with unilateral amygdala enlargement.

Authors:  Zhen Fan; Bing Sun; Li-Qin Lang; Jie Hu; N U Farrukh Hameed; Zi-Xuan Wei; Qi-Yuan Zhuang; Jia-Jun Cai; Feng-Tao Liu; Yi-Ting Mao; Rui Feng; Li Pan
Journal:  Neurol Sci       Date:  2020-10-12       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.